SOX17
Basic information
Region (hg38): 8:54457935-54460892
Links
Phenotypes
GenCC
Source:
- vesicoureteral reflux 3 (Definitive), mode of inheritance: AD
- familial vesicoureteral reflux (Supportive), mode of inheritance: AD
- vesicoureteral reflux 3 (Strong), mode of inheritance: AD
- vesicoureteral reflux 3 (Limited), mode of inheritance: AD
- pulmonary arterial hypertension (Definitive), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Vesicoureteral reflux 3 | AD | Renal | Monitoring and intervention related to vesicoureteral reflux may be beneficial in terms of helping to preserve renal function | Renal | 20960469 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (1 variants)
- Pulmonary arterial hypertension (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SOX17 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 30 | 35 | ||||
missense | 67 | 80 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 5 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 12 | |||||
Total | 2 | 3 | 71 | 43 | 15 |
Variants in SOX17
This is a list of pathogenic ClinVar variants found in the SOX17 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
8-54458059-C-T | Benign (Nov 12, 2018) | |||
8-54458180-C-A | Vesicoureteral reflux 3 | Uncertain significance (Feb 01, 2024) | ||
8-54458189-G-T | SOX17-related disorder | Uncertain significance (Sep 16, 2022) | ||
8-54458195-G-C | Vesicoureteral reflux 3 | Conflicting classifications of pathogenicity (May 16, 2024) | ||
8-54458195-G-T | Likely benign (Jul 25, 2022) | |||
8-54458196-C-G | Inborn genetic diseases | Uncertain significance (Nov 07, 2023) | ||
8-54458227-G-A | Vesicoureteral reflux 3 | Uncertain significance (Jan 27, 2024) | ||
8-54458236-C-A | Benign/Likely benign (Aug 01, 2024) | |||
8-54458238-G-A | Vesicoureteral reflux 3 | Uncertain significance (Feb 20, 2024) | ||
8-54458255-C-T | Likely benign (Sep 15, 2023) | |||
8-54458259-G-T | Vesicoureteral reflux 3 | Uncertain significance (Apr 30, 2024) | ||
8-54458302-C-T | Uncertain significance (May 17, 2022) | |||
8-54458305-C-A | Inborn genetic diseases • Vesicoureteral reflux 3 | Uncertain significance (Feb 08, 2024) | ||
8-54458307-G-C | Vesicoureteral reflux 3 | Uncertain significance (May 13, 2024) | ||
8-54458308-G-A | Inborn genetic diseases | Uncertain significance (Sep 27, 2022) | ||
8-54458330-C-T | Uncertain significance (Apr 20, 2021) | |||
8-54458334-T-C | Vesicoureteral reflux 3 | Uncertain significance (Jan 08, 2024) | ||
8-54458346-C-G | Sox17- related disorders | Likely pathogenic (-) | ||
8-54458352-A-T | Inborn genetic diseases | Uncertain significance (Mar 02, 2022) | ||
8-54458359-C-T | Uncertain significance (Dec 21, 2023) | |||
8-54458379-G-A | Inborn genetic diseases | Uncertain significance (Aug 30, 2022) | ||
8-54458381-C-G | Uncertain significance (Dec 24, 2021) | |||
8-54458383-A-G | Vesicoureteral reflux 3 | Likely pathogenic (Jul 18, 2022) | ||
8-54458386-G-A | Uncertain significance (Sep 27, 2022) | |||
8-54458389-A-G | Vesicoureteral reflux 3 | Uncertain significance (Jan 14, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SOX17 | protein_coding | protein_coding | ENST00000297316 | 2 | 2954 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.885 | 0.115 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.774 | 199 | 232 | 0.857 | 0.0000107 | 2618 |
Missense in Polyphen | 86 | 110.83 | 0.776 | 1264 | ||
Synonymous | -1.36 | 122 | 104 | 1.17 | 0.00000521 | 855 |
Loss of Function | 2.86 | 1 | 11.4 | 0.0876 | 5.00e-7 | 118 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as transcription regulator that binds target promoter DNA and bends the DNA. Binds to the sequences 5'- AACAAT-'3 or 5'-AACAAAG-3'. Modulates transcriptional regulation via WNT3A. Inhibits Wnt signaling. Promotes degradation of activated CTNNB1. Plays a key role in the regulation of embryonic development. Required for normal looping of the embryonic heart tube. Required for normal development of the definitive gut endoderm. Probable transcriptional activator in the premeiotic germ cells (By similarity). {ECO:0000250}.;
- Pathway
- Wnt signaling pathway - Homo sapiens (human);Cardiac Progenitor Differentiation;Endoderm Differentiation;Mesodermal Commitment Pathway;Wnt Signaling Pathway;Signaling by WNT;Signal Transduction;Deactivation of the beta-catenin transactivating complex;TCF dependent signaling in response to WNT
(Consensus)
Recessive Scores
- pRec
- 0.226
Haploinsufficiency Scores
- pHI
- 0.102
- hipred
- Y
- hipred_score
- 0.837
- ghis
- 0.423
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.726
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sox17
- Phenotype
- immune system phenotype; digestive/alimentary phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; reproductive system phenotype; liver/biliary system phenotype; embryo phenotype; homeostasis/metabolism phenotype; cellular phenotype; muscle phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype;
Zebrafish Information Network
- Gene name
- sox17
- Affected structure
- erythroid lineage cell
- Phenotype tag
- abnormal
- Phenotype quality
- decreased amount
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;angiogenesis;vasculogenesis;endoderm formation;inner cell mass cellular morphogenesis;heart looping;cardiogenic plate morphogenesis;embryonic heart tube morphogenesis;outflow tract morphogenesis;negative regulation of Wnt signaling pathway involved in heart development;regulation of transcription, DNA-templated;spermatogenesis;endodermal cell fate determination;rostrocaudal neural tube patterning;signal transduction involved in regulation of gene expression;cell differentiation;negative regulation of cell growth;protein destabilization;embryonic heart tube development;cell migration involved in gastrulation;negative regulation of mesodermal cell fate specification;mRNA transcription by RNA polymerase II;positive regulation of cell differentiation;positive regulation of protein catabolic process;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;regulation of embryonic development;embryonic foregut morphogenesis;positive regulation of skeletal muscle tissue development;stem cell fate specification;protein stabilization;canonical Wnt signaling pathway;endocardium formation;regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification;cardiac cell fate determination;heart formation;endocardial cell differentiation;common bile duct development;gall bladder development;endodermal digestive tract morphogenesis;renal system development;regulation of stem cell proliferation;negative regulation of canonical Wnt signaling pathway;cellular response to leukemia inhibitory factor;regulation of stem cell division;regulation of cardiac cell fate specification
- Cellular component
- nucleus;nucleoplasm;transcription factor complex;nuclear transcription factor complex
- Molecular function
- DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;transcription coactivator activity;protein binding;beta-catenin binding;transcription factor binding;sequence-specific DNA binding;transcription regulatory region DNA binding;protein heterodimerization activity